Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025)

Eton Pharmaceuticals' Amortizatization of Intangibles history spans 6 years, with the latest figure at -$307000.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 6240.0% year-over-year to -$307000.0; the TTM value through Sep 2025 reached $40000.0, up 33.33%, while the annual FY2024 figure was $70000.0, 4.48% up from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was -$307000.0 at Eton Pharmaceuticals, down from $325000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $325000.0 in Q2 2025 and bottomed at -$307000.0 in Q3 2025.
  • The 5-year median for Amortizatization of Intangibles is $30000.0 (2022), against an average of $22894.7.
  • The largest YoY upside for Amortizatization of Intangibles was 1313.04% in 2025 against a maximum downside of 6240.0% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $38000.0 in 2021, then tumbled by 189.47% to -$34000.0 in 2022, then skyrocketed by 32.35% to -$23000.0 in 2023, then surged by 404.35% to $70000.0 in 2024, then crashed by 538.57% to -$307000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Amortizatization of Intangibles are -$307000.0 (Q3 2025), $325000.0 (Q2 2025), and $17000.0 (Q1 2025).